ARTICLE | Product Development
CervoMed and Cognition Therapeutics testing different therapeutic hypotheses in dementia with Lewy bodies
By Selina Koch, Executive Editor
November 19, 2024 2:23 AM UTC
Ask a dementia expert what the most common neurodegenerative disease is that people have never heard of and the answer will be dementia with Lewy bodies. Affecting an estimated 1.4 million people in the U.S. alone, the condition ranks second only to Alzheimer’s among dementias, and third, after Alzheimer’s and Parkinson’s, among neurodegenerative diseases.
Despite its prevalence, dementia with Lewy bodies (DLB) remains underdiagnosed and less understood than other neurodegenerative disorders. No drugs have been approved to treat the condition. …
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/654194/an-understudied-dementia-soon-to-get-a-pair-of-phase-ii-readouts